September 2010
Worldwide Biotech;Sep2010, Vol. 22 Issue 9, p6
Trade Publication
The article reports on the International Society of Oncology and Biomarkers Congress Scientific Committee's acceptance of BioCurex Inc.'s presentation about the RECAF blood test potential to monitor cancer recurrence and treatment. BioCurex chief executive officer Ricardo Moro has also been invited to co-chair a panel discussion on biomarker statistics and present challenges in developing cancer markers at the meeting, which will be held in September 2010 in Munich, Germany. The importance of an affordable and reliable cancer marker test is described.


Related Articles

  • BioCurex Updates Its Shareholders.  // Biotech Financial Reports;Jul2011, Vol. 18 Issue 7, p5 

    The article reports that chief executive officer (CEO) Ricardo Moro, of cancer diagnostics company BioCurex Inc., has sent a letter to update shareholders on the company's current and future programs. The letter provides information on programs including synthetic peptide for canine RECAF tests,...

  • Q&A: Victor Velculescu. Bender, Eric // Nature;5/14/2015 Supplement, Vol. 521 Issue 7551, pS9 

    An interview with oncologist Victor Velculescu is presented. When asked what circulating tumor DNA (ctDNA) was and how it could help in cancer therapeutics, he said ctDNA was fragments of DNA that escaped from tumors into the bloodstream which provides genetic clues to detect and analyse the...

  • Red Blood cell distribution width: an emerging diagnostic factor of acute appendicitis? Karagöz, Ergenekon; Tanoglu, Alpaslan // World Journal of Emergency Surgery;2013, Vol. 8 Issue 1, p54 

    Acute appendicitis is the most common surgical abdominal emergency. Immediate diagnosis of this disease is crucial, because this condition can lead to appendiceal perforation, potential peritonitis, and even death. We read with great interest the article 'The role of red cell distribution width...

  • ON THE HORIZON.  // Patient Care for the Nurse Practitioner;Sep2005, Vol. 8 Issue 9, p4 

    The article reveals that biomarkers in a tissue or tumor sample may help in the early detection of cancer. Most biomarkers can be measured on a continuum, and their presence or absence does not necessarily indicate disease but it may signal the presence of a new cancerous lesion, cancer...

  • Blood Biomarkers for the Diagnosis of Acute Cerebrovascular Diseases: A Prospective Cohort Study. Whiteley, William; Wardlaw, Joanna; Dennis, Martin; Lowe, Gordon; Rumley, Ann; Sattar, Naveed; Welsh, Paul; Green, Alison; Andrews, Mary; Graham, Catriona; Sandercock, Peter // Cerebrovascular Diseases;Aug2011, Vol. 32 Issue 2, p141 

    Background: The diagnosis of stroke or TIA in the emergency department is difficult, though important for early treatment. Circulating biomarkers might improve upon clinical assessment at admission. Methods: We recruited symptomatic patients with suspected stroke or TIA and drew blood soon after...

  • INTRODUCTION. LEUNG, RONALD; ZHANG, GRACE // Meducator;Apr2015, Issue 27, p2 

    The article introduces various reports published within the issue, including one about angiogenesis, one about methods of reducing cancer relapse rates and another on the use of circulating tumor DNA in the blood as a cancer biomarker.

  • Application of MALDI/SELDI Mass Spectrometry to Cancer Biomarker Discovery and Validation. Ahmed, Farid E. // Current Proteomics;Dec2008, Vol. 5 Issue 4, p224 

    This article provides a focused perspective on the application of MALDI/SELDI mass spectrometry (MS)- based technologies to biomarker discovery and validation in various biological materials, which might eventually serve as the basis for new clinical tests to improve diagnosis, guide...

  • Detect schizophrenia via blood test.  // MLO: Medical Laboratory Observer;Nov2010, Vol. 42 Issue 11, p34 

    The article reports on the importance of blood-based diagnostic test in the detection of schizophrenia.

  • Are Samples in Your Freezer Still Good for Biomarker Discovery? Kushnir, Mark M. // American Journal of Clinical Pathology;Sep2013, Vol. 140 Issue 3, p287 

    The article explores the important role of disease and diagnostic markers in detecting diseases and patient care. It is noted that few new biomakers have been discovered despite great progress in instrumentation and analytical techniques. A study which investigated blood collection and sample...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics